HPV-Related Neoplasia in HIV Infection: Proposed Mechanisms for Development of Malignancy

AIDS-Related Cancers and Their Treatment

Volumn , Issue , 2016, Pages 209-222

  Critchlow, Cathy W ^a   Kiviat, Nancy B ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84890113417     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b14829-13     Document Type: Chapter

References (65)

1. Parkin DM, Laara E, Muir CS. Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 41:184–197, 1988.
2. Lorincz AT, Reid R. Jenson AB, Cullen A, Greenberg MD, Lancaster WD, Kurman RJ. Human papillomavirus infection of the cervix: relative risk associations of fifteen common anogenital types. Obstet Gynecol 79:328–337, 1992.
3. zur Hausen H. Human genital cancers: synergism between two virus infections or synergism between a virus infection and initiating events? Lancet 2:1370–1372, 1982.
4. zur Hausen H. The role of papillomaviruses in anogenital cancer. Scand J Infect Dis 69:107–111, 1990.
5. zur Hausen H. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 184:9–13, 1991.
6. Johnson JC, Burnett AF, Willet GD, Young MA, Doniger J. High frequency of latent and clinical human papillomavirus cervical infections in immunocompromised human immunodeficiency virus-infected women. Obstet Gynecol 79:321–327, 1992.
7. St Louis ME, Icenogle JP, Manzila T, Kamenga M, Ryder RW, Heyward WL, Reeves WC. Genital types of papillomavirus in children of women with HIV-1 infection in Kinshasa, Zaire. Int J Cancer 54;181–184, 1993.
8. Sun X-W, Kuhn L, Ellerbrock TV, Chiasson MA, Bush TJ, Wright TC. Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med 337:1343–1349, 1997.
9. Sun X-W, Ellerbrock TV, Lungu O, Chiasson MA, Bush TJ, Wright TC Jr. Human papillomavirus infection in human immunodeficiency virus seropositive women. Obstet Gynecol 85(5 pt 1):680–686, 1995.
10. Van Doornum GJ, Van den Hoek JA, Van Ameijden EJ, Van Haastrecht HJ, Roos MT, Henquet CJ, Quint WG, Coutinho RA. Cervical HPV infection among HIVinfected prostitutes addicted to hard drugs. J Med Virol 41:185–190, 1993.
11. Williams AB, Darragh TM, Vranizan K, Ochia C, Moss A, Palefsky JM. Anal and cervical epithelial abnormalities in human immunodeficiency virus-infected women. Obstet Gynecol 82:205–211, 1994.
12. Kreiss JK, Kiviat NB, Plummer FA, Roberts PL, Waiyaki P, Ngugi E, Holmes KK. Human immunodeficiency virus, human papillomavirus, and cervical intraepithelial neoplasia in Nairobi prostitutes. Sex Transm Dis 19:54–59, 1992.
13. Laga M, Icenogle JP, Marsella R, Monoka AT, Nzila N, Ryder RW, Vermund SH, Heyward WL, Nelson A, Reeves WC. Genital papillomavirus infection and cervical dysplasia—opportunistic complications of HIV infection. Int J Cancer 50:45–48, 1992.
14. Vermund SH, Kelley KF, Klein RS, Feingold AR, Schreiber K, Munk G, Burk RD. High risk of human papillomavirus infection and cervical squamous intraepithelial lesions among women with symptomatic human immunodeficiency virus infection. Am J Obstet Gynecol 165:392–400, 1991.
15. Feingold AR, Vermund SH, Burk RD, Kelley KF, Schrager LW, Schreiber K, Munk G, Friedland GH, Klein RS. Cervical cytologic abnormalities and papillomavirus in women infected with human immunodeficiency virus. J Acquir Immune Defic Syndr 3:896–903, 1990.
16. Spinillo A, Tenti P, Zappatore R, Barbarini G, Maccabruni A, Carrata L, Guaschino S. Prevalence, diagnosis and treatment of lower genital neoplasia in women with human immunodeficiency virus infection. Eur J Obstet Gynecol Reprod Biol 43: 235–241, 1992.
17. Rellihan MA, Dooley DP, Burke TW, Berkland ME, Longfield RN. Rapidly progressing cervical cancer in a patient with human immunodeficiency virus infection. Gynecol Oncol 36:435–438, 1990.
18. Smith JK, Kitchen VS, Botcherby M, Hepburn M, Wells C, Gor D, Forster SM, Harris JR, Steer P, Mason P. Is HIV infection associated with an increase in the prevalence of cervical neoplasia? Br J Obstet Gynaecol 100:149–153, 1993.
19. Langley CL, Benga-De E, Critchlow CW, Ndoye I, Mbengue-Ly MD, Kuypers J, Woto-Gaye G, Mboup S, Bergeron C, Holmes KK, Kiviat NB. HIV 1, HIV 2, human papillomavirus infection and cervical neoplasia in high risk African women. AIDS 10:413–417, 1996.
20. Wright TC Jr, Ellerbrock TV, Chiasson MA, Van Devanter N, Sun XW. Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors, and validity of Papanicolaou smears. Obstet Gynecol 84: 591–597, 1994.
21. Rabkin CS, Biggar RJ, Baptiste MS, Abe T, Kohler BA, Nasca PC. Cancer incidence trends in women at high risk of human immunodeficiency virus (HIV) infection. Int J Cancer 55:208–212, 1993.
22. Grant AD, Djomand G, De Cock KM. Natural history and spectrum of disease in adults with HIV/AIDS in Africa. AIDS 11(suppl B):S43–S54, 1997.
23. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report. 9:12– 17, 1997.
24. Goedert JJ, Cote TR, Virgo P, Scoppa SM, Kingma DW, Gail MH, Jaffe ES, Biggar RJ. Spectrum of AIDS-associated malignant disorders. Lancet 351:1833–1839, 1998.
25. Shah KV, Howley PM. Papillomaviruses. In: Fields BN, Knipe DM, Howley PM, Chanock RM, Melnick JL, Monath TP, Roizman B, Straus SE, eds. Fields Virology. 3rd ed. Philadelphia: Lippincott–Raven, 1996:2077–2109.
26. Howley PM. Papillomavirinae: the viruses and their replication. In: Fields BN, Knipe DM, Howley PM, Chanock RM, Melnick JL, Monath TP, Roizman B, Straus SE, eds. Fields Virology. 3rd ed. Philadelphia: Lippincott Raven, 1996:2045–2076.
27. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med 102:3–8, 1997.
28. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 338:423–428, 1998.
29. Burk RD, Kelly P, Feldman J, Bromberg J, Vermund SH, DeHovitz JA, Landesman SH. Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors. Sex Transm Dis 23:333–341, 1996.
30. Ferenczy A. Epidemiology and clinical pathophysiology of condylomata acuminata. Am J Obstet Gynecol 172(4 suppl):1331–1339, 1995.
31. Fletcher S, Norval M. On the nature of the deep cellular disturbances in human papillomavirus infection of squamous cervical epithelium. Lancet 2:546–549, 1983.
32. Schoenfeld A, Ziv E. Levavi H, Samra Z, Ovadia J. Laser versus loop electrosurgical excision in vulvar condyloma for eradication of subclinical reservoir demonstrated by assay for 2′5′ oligosynthetase human papillomavirus. Gynecol Obstet Invest 40: 46–51, 1995.
33. Bauman NM, Smith RJ. Recurrent respiratory papillomatosis. Pediatr Clin North Am 43:1385–1401, 1996.
34. Luchtefeld MA. Perianal condylomata acuminata. Surg Clin North Am 74:1327– 1338, 1994.
35. Frisch M, Glimelius B, van den Brule AJC, Wohlfahrt J, Meijer CJLM, Walboomers JMM, Goldman S, Svensson C, Adami H-O, Melbye M. Sexually transmitted infection as a cause of anal cancer. N Engl J Med 337:1350–1358, 1997.
36. Chua KL, Hjerpe A. Persistence of human papillomavirus (HPV) infections preceding cervical carcinoma. Cancer 77:121–127, 1996. J Med 327:1272–1278, 1992.
37. Munger K, Phelps WC, Bubb V, Howley PM, Schlegel R. The E6 and E7 genes of the human papillomavirus together are necessary and sufficient for transformation of primary human keratinocytes. J Virol 63:4417–4421, 1989.
38. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus 16 and 18 promotes the degradation of p53. Cell 63:1129–1136, 1990.
39. Dyson N, Howley PM, Munger K, Harlow E. The human papillomavirus-16 E7 oncoprotein is able to bind the retinoblastoma gene product. Science 243:934–937, 1989.
40. Scheffner M, Romanczuk H, Munger K, Huibregtse JM, Mietz JA, Howley PM. Functions of human papillomavirus proteins. Curr Top Microbiol Immunol 186:83– 99, 1994.
41. McDougall JK. Immortalization and transformation of human cells by HPV. Curr Top Microbiol Immunol 186:101–119, 1994.
42. Atkin NB, Baker MC. Non-random chromosome changes in carcinoma of the cervix uteri. I. Nine near diploid tumors. Cancer Genet Cytogenet 7:209–222, 1982.
43. Teyssier JR. The chromosomal analysis of human solid tumors: a triple challenge. Cancer Genet Cytogenet 37:103–125, 1989.
44. Array I, Tyring SK. Status of local cellular immunity in interferon-responsive and nonresponsive human papillomavirus-associated lesions. Sex Transm Dis 23:475– 480, 1996.
45. McArdle JP, Mueller K. Quantitative assessment of Langerhans cells in human cervical extraepithelial neoplasia and wart virus infection. Am J Obstet Gynecol 154: 509–515, 1986.
46. Koutsky LA, Galloway DA, Holmes KK. Epidemiology of genital human papillomavirus infection. Epidemiol Rev 10:122–163, 1988.
47. Schneider A. Pathogenesis of genital HPV infection. Genitourin Med 69:165–173, 1993.
48. Critchlow CW, Hawes SE, Kuypers JM, Goldbaum GM, Holmes KK, Surawicz CM, Kiviat NB. Effect of HIV infection on the natural history of anal human papillomavirus infection. AIDS 12:1177–1184, 1998.
49. Quinn TC, Goodell SE, Mkrtichian E, Schuffler MD, Wang SP, Stamm WE, Holmes KK. Chlamydia trachomatis proctitis. N Engl J Med 305:195–200, 1981.
50. Kanitakis J, Misery L, Nicolas JF, Lyonnet S, Chouvet B, Haftek M, Faure M, Claudy A, Thivolet J. Disseminated superficial porokeratosis in a patient with AIDS. Br J Dermatol 131:284–289, 1994.
51. Knight SC, Macatonia SE, Patterson S. HIV-1 infection of dendritic cells. Int Rev Immunol 6:163–175, 1990.
52. Lehtinen M, Rantala I, Toivonen A, Luoto H, Aine R, Lauslahti K, Yla Outinen A, Romppanen U, Paavonen J. Depletion of Langerhans cells in cervical HPV infection is associated with replication of the virus. APMIS 101:833–837, 1993.
53. Tay SK, Jenkins D, Maddox P, Campion M, Singer A. Subpopulations of Langerhans' cells in cervical neoplasia. Br J Obstet Gynaecol 94:10–15, 1987.
54. Hughes RG, Norval M, Howie SE. Expression of major histocompatibility class II antigens by Langerhans' cells in cervical intraepithelial neoplasia. J Clin Pathol 41: 253–259, 1998.
55. Knight SC, Macatonia SE, Patterson S. Infection of dendritic cells with HIV-1: virus load regulates stimulation and suppression of T-cell activity. Res Virol 144:75–80, 1993.
56. Vernon SD, Hart CE, Reeves WC, Icenogle JP. The HIV-1 tat protein enhances E2-dependent human papillomavirus 16 transcription. Virus Res 27:133–145, 1993.
57. Tornesselo ML, Buonguro FM, Beth Giraldo E, Giraldo G. Human immunodeficiency virus type 1 tat gene enhances human papillomavirus early gene expression. Intervirology 36:57–64, 1993.
58. Xi LF, Demers GW, Koutsky LA, Kiviat NB, Kuypers J, Watts DH, Holmes KK, Galloway DA. Analysis of human papillomavirus type 16 variants indicates establishment of persistent infection. J Infect Dis 172:747–55, 1995.
59. Chan SY, Ho L, Ong CK, Chow V, Drescher B, Durst M, ter Meulen J, Villa L, Luande F, Mgaya HN, Bernard HU. Molecular variants of human papillomavirus type 16 from four continents suggest ancient pandemic spread of the virus and its coevolution with humankind. J Virol 66:2057–2066, 1992.
60. Yamada T, Manos M, Peto J, Greer CE, Munoz N, Bosch FX, Wheeler CM. Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol 71:2463–2472, 1997.
61. Londesborough P, Ho L, Terry G, Cuzick J, Wheeler C, Singer A. Human papillomavirus genotype as a predictor of persistence and development of high grade lesions in women with minor cervical abnormalities. Int J Cancer 69:364–368, 1996.
62. Hecht JL, Kadish S, Jiang G, Burk RD. Genetic characterization of the human papillomavirus (HPV) 18 E2 gene in clinical specimens suggests the presence of a subtype with decreased oncogenic potential. Int J Cancer 60:369–376, 1995.
63. Bavin PJ, Walker PG, Emery VC. Sequence microheterogeneity in the long control region of clinical isolates of human papillomavirus type 16. J Med Virol 39:267– 272, 1993.
64. May M, Dong XP, Stubenrauch F, Fuchs PG, Pfister H, The E6/E7 promoter of extrachromosomal HPV16 DNA in cervical cancers escapes from cellular repression by mutation of target sequences for YY1. EMBO J 13:1460–1466, 1994.
65. Xi LF, Koutsky LA, Galloway DA, Kuypers J, Hughes JP, Wheeler CM, Holmes KK, Kiviat NB. Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. J Natl Cancer Inst 89:796–802, 1997.